REFERENCES
2. Bulut SD, Döndaş HA, Celebioglu HU, Sansano JM, Döndaş NY. Recent insights about probiotics related pharmabiotics in pharmacology: prevention and management of diseases. Probiotics Antimicrob Proteins. 2025;17:2262-92.
3. Ma T, Li Y, Yang N, et al. Efficacy of a postbiotic and its components in promoting colonic transit and alleviating chronic constipation in humans and mice. Cell Rep Med. 2025;6:102093.
4. Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18:649-67.
5. You J, Liu W, Huang Y, et al. Akkermansia muciniphila PROBIO ameliorates overweight via gut microbiota modulation：a randomized controlled trial. Food Sci Hum Wellness. 2025.
6. van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213-28.
7. Dorward DW, Garon CF. DNA is packaged within membrane-derived vesicles of gram-negative but not gram-positive bacteria. Appl Environ Microbiol. 1990;56:1960-2.
8. Jahromi LP, Fuhrmann G. Bacterial extracellular vesicles: understanding biology promotes applications as nanopharmaceuticals. Adv Drug Deliv Rev. 2021;173:125-40.
9. Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17:13-24.
10. Xie J, Li Q, Nie S. Bacterial extracellular vesicles: an emerging postbiotic. Trends Food Sci Technol. 2024;143:104275.
11. Wang S, Gao J, Wang Z. Outer membrane vesicles for vaccination and targeted drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11:e1523.
12. Luo R, Chang Y, Liang H, et al. Interactions between extracellular vesicles and microbiome in human diseases: new therapeutic opportunities. Imeta. 2023;2:e86.
13. Li M, Zhou H, Yang C, et al. Bacterial outer membrane vesicles as a platform for biomedical applications: an update. J Control Release. 2020;323:253-68.
14. Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 2015;15:375-87.
15. Bertani B, Ruiz N. Function and biogenesis of Lipopolysaccharides. EcoSal Plus. 2018;8:ESP-0001.
16. Xie J, Li Q, Haesebrouck F, Van Hoecke L, Vandenbroucke RE. The tremendous biomedical potential of bacterial extracellular vesicles. Trends Biotechnol. 2022;40:1173-94.
17. Sartorio MG, Pardue EJ, Feldman MF, Haurat MF. Bacterial outer membrane vesicles: from discovery to applications. Annu Rev Microbiol. 2021;75:609-30.
18. Li Q, Chen X, Xie J, Nie S. Engineered bacterial extracellular vesicles: developments, challenges, and opportunities. Engineering. 2025;54:291-307.
19. Li R, Helbig L, Fu J, et al. Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy. Res Microbiol. 2019;170:74-9.
20. Liu H, Geng Z, Su J. Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy. Extracell Vesicles Circ Nucl Acids. 2022;3:63-86.
21. Lieberman LA. Outer membrane vesicles: a bacterial-derived vaccination system. Front Microbiol. 2022;13:1029146.
22. Ji N, Wang F, Wang M, Zhang W, Liu H, Su J. Engineered bacterial extracellular vesicles for central nervous system diseases. J Control Release. 2023;364:46-60.
23. Zheng K, Feng Y, Li L, Kong F, Gao J, Kong X. Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors. Theranostics. 2024;14:761-87.
24. Liu H, Zhang Q, Wang S, Weng W, Jing Y, Su J. Bacterial extracellular vesicles as bioactive nanocarriers for drug delivery: advances and perspectives. Bioact Mater. 2022;14:169-81.
25. Nie X, Li Q, Chen X, Onyango S, Xie J, Nie S. Bacterial extracellular vesicles: vital contributors to physiology from bacteria to host. Microbiol Res. 2024;284:127733.
26. Peregrino ES, Castañeda-Casimiro J, Vázquez-Flores L, et al. The role of bacterial extracellular vesicles in the immune response to pathogens, and therapeutic opportunities. Int J Mol Sci. 2024;25:6210.
27. Bittel M, Reichert P, Sarfati I, et al. Visualizing transfer of microbial biomolecules by outer membrane vesicles in microbe-host-communication in vivo. J Extracell Vesicles. 2021;10:e12159.
28. Schaack B, Mercier C, Katby M, et al. Rapid biodistribution of fluorescent outer-membrane vesicles from the intestine to distant organs via the blood in mice. Int J Mol Sci. 2024;25:1821.
29. Lee KS, Kim Y, Lee JH, et al. Human probiotic lactobacillus paracasei-derived extracellular vesicles improve tumor necrosis factor-α-induced inflammatory phenotypes in human skin. Cells. 2023;12:2789.
30. Han F, Wang W, Shi M, et al. Outer membrane vesicles from bacteria: role and potential value in the pathogenesis of chronic respiratory diseases. Front Cell Infect Microbiol. 2022;12:1093327.
31. Meers PR, Liu C, Chen R, et al. Vesicular delivery of the antifungal antibiotics of lysobacter enzymogenes C3. Appl Environ Microbiol. 2018;84:e01353-18.
32. Kim JH, Jeun EJ, Hong CP, et al. Extracellular vesicle-derived protein from Bifidobacterium longum alleviates food allergy through mast cell suppression. J Allergy Clin Immunol. 2016;137:507-16.e8.
33. Chelakkot C, Choi Y, Kim DK, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions. Exp Mol Med. 2018;50:e450.
34. Ashrafian F, Shahriary A, Behrouzi A, et al. Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery vector for amelioration of obesity in mice. Front Microbiol. 2019;10:2155.
35. Díez-Sainz E, Milagro FI, Riezu-Boj JI, Lorente-Cebrián S. Effects of gut microbiota-derived extracellular vesicles on obesity and diabetes and their potential modulation through diet. J Physiol Biochem. 2022;78:485-99.
36. Chen CY, Rao SS, Yue T, et al. Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis. Sci Adv. 2022;8:eabg8335.
37. Kang CS, Ban M, Choi EJ, et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One. 2013;8:e76520.
38. Shen Y, Giardino Torchia ML, Lawson GW, Karp CL, Ashwell JD, Mazmanian SK. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe. 2012;12:509-20.
39. Ma L, Lyu W, Song Y, et al. Anti-inflammatory effect of Clostridium butyricum-derived extracellular vesicles in ulcerative colitis: impact on host microRNAs expressions and gut microbiome profiles. Mol Nutr Food Res. 2023;67:e2200884.
40. Raftar SKA, Ashrafian F, Abdollahiyan S, et al. The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury. Sci Rep. 2022;12:2453.
41. Gu Z, Li F, Liu Y, et al. Exosome-like nanoparticles from Lactobacillus rhamnosus GG protect against alcohol-associated liver disease through intestinal Aryl hydrocarbon receptor in mice. Hepatol Commun. 2021;5:846-64.
42. Jo CS, Myung CH, Yoon YC, et al. The effect of Lactobacillus plantarum extracellular vesicles from Korean women in their 20s on skin aging. Curr Issues Mol Biol. 2022;44:526-40.
43. Gan Y, Chen X, Yi R, Zhao X. Antioxidative and anti-inflammatory effects of Lactobacillus plantarum ZS62 on alcohol-induced subacute hepatic damage. Oxid Med Cell Longev. 2021;2021:7337988.
44. Wang L, Zhao Z, Zhao L, et al. Lactobacillus plantarum DP189 reduces α-SYN aggravation in MPTP-induced Parkinson’s disease mice via regulating oxidative damage, inflammation, and gut microbiota disorder. J Agric Food Chem. 2022;70:1163-73.
45. Ashrafian F, Behrouzi A, Shahriary A, et al. Comparative study of effect of Akkermansia muciniphila and its extracellular vesicles on toll-like receptors and tight junction. Gastroenterol Hepatol Bed Bench. 2019;12:163-8.
46. Liang X, Dai N, Sheng K, et al. Gut bacterial extracellular vesicles: important players in regulating intestinal microenvironment. Gut Microbes. 2022;14:2134689.
47. Wang X, Lin S, Wang L, et al. Versatility of bacterial outer membrane vesicles in regulating intestinal homeostasis. Sci Adv. 2023;9:eade5079.
48. Rodovalho VR, da Luz BSR, Rabah H, et al. Extracellular vesicles produced by the probiotic Propionibacterium freudenreichii CIRM-BIA 129 mitigate inflammation by modulating the NF-κB pathway. Front Microbiol. 2020;11:1544.
49. Choi J, Kim YK, Han PL. Extracellular vesicles derived from Lactobacillus plantarum increase BDNF expression in cultured hippocampal neurons and produce antidepressant-like effects in mice. Exp Neurobiol. 2019;28:158-71.
50. Yang Z, Gao Z, Yang Z, et al. Lactobacillus plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis. Pharmacol Res. 2022;182:106332.
51. Kim OY, Park HT, Dinh NTH, et al. Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response. Nat Commun. 2017;8:626.
52. Liu H, Zhang H, Han Y, Hu Y, Geng Z, Su J. Bacterial extracellular vesicles-based therapeutic strategies for bone and soft tissue tumors therapy. Theranostics. 2022;12:6576-94.
53. Qiao L, Rao Y, Zhu K, Rao X, Zhou R. Engineered remolding and application of bacterial membrane vesicles. Front Microbiol. 2021;12:729369.
54. Balhuizen MD, Veldhuizen EJA, Haagsman HP. Outer membrane vesicle induction and isolation for vaccine development. Front Microbiol. 2021;12:629090.
55. Premjani V, Tilley D, Gruenheid S, Le Moual H, Samis JA. Enterohemorrhagic Escherichia coli OmpT regulates outer membrane vesicle biogenesis. FEMS Microbiol Lett. 2014;355:185-92.
56. Elhenawy W, Bording-Jorgensen M, Valguarnera E, Haurat MF, Wine E, Feldman MF. LPS remodeling triggers formation of outer membrane vesicles in salmonella. mBio. 2016;7:e00940-16.
57. Laman JD, ’t Hart BA, Power C, Dziarski R. Bacterial peptidoglycan as a driver of chronic brain inflammation. Trends Mol Med. 2020;26:670-82.
58. Liu Y, Chen J, Raj K, et al. A universal strategy to promote secretion of G+/G- bacterial extracellular vesicles and its application in host innate immune responses. ACS Synth Biol. 2023;12:319-28.
59. Chen J, Liu M, Chen S, et al. Engineered therapeutic bacteria with high-yield membrane vesicle production inspired by eukaryotic membrane curvature for treating inflammatory bowel disease. ACS Nano. 2025;19:2405-18.
60. Moon DC, Choi CH, Lee JH, et al. Acinetobacter baumannii outer membrane protein A modulates the biogenesis of outer membrane vesicles. J Microbiol. 2012;50:155-60.
61. Schwechheimer C, Kulp A, Kuehn MJ. Modulation of bacterial outer membrane vesicle production by envelope structure and content. BMC Microbiol. 2014;14:324.
62. McBroom AJ, Johnson AP, Vemulapalli S, Kuehn MJ. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J Bacteriol. 2006;188:5385-92.
63. Gong X, Liu S, Xia B, et al. Oral delivery of therapeutic proteins by engineered bacterial type zero secretion system. Nat Commun. 2025;16:1862.
64. McBroom AJ, Kuehn MJ. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol. 2007;63:545-58.
65. Roier S, Zingl FG, Cakar F, et al. A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria. Nat Commun. 2016;7:10515.
66. Zingl FG, Kohl P, Cakar F, et al. Outer membrane vesiculation facilitates surface exchange and in vivo adaptation of Vibrio cholerae. Cell Host Microbe. 2020;27:225-37.e8.
67. Mozaheb N, Mingeot-Leclercq MP. Membrane vesicle production as a bacterial defense against stress. Front Microbiol. 2020;11:600221.
68. Gerritzen MJH, Martens DE, Uittenbogaard JP, Wijffels RH, Stork M. Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis. Sci Rep. 2019;9:4716.
69. van de Waterbeemd B, Zomer G, van den Ijssel J, et al. Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development. PLoS One. 2013;8:e54314.
70. Gerritzen MJH, Maas RHW, van den Ijssel J, et al. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis. Microb Cell Fact. 2018;17:157.
71. Mashburn-Warren L, Howe J, Garidel P, et al. Interaction of quorum signals with outer membrane lipids: insights into prokaryotic membrane vesicle formation. Mol Microbiol. 2008;69:491-502.
72. McMahon KJ, Castelli ME, García Vescovi E, Feldman MF. Biogenesis of outer membrane vesicles in Serratia marcescens is thermoregulated and can be induced by activation of the Rcs phosphorelay system. J Bacteriol. 2012;194:3241-9.
73. Bonnington KE, Kuehn MJ. Outer membrane vesicle production facilitates LPS remodeling and outer membrane maintenance in salmonella during environmental transitions. mBio. 2016;7:e01532-16.
74. Gamalier JP, Silva TP, Zarantonello V, Dias FF, Melo RC. Increased production of outer membrane vesicles by cultured freshwater bacteria in response to ultraviolet radiation. Microbiol Res. 2017;194:38-46.
75. Roberts R, Moreno G, Bottero D, et al. Outer membrane vesicles as acellular vaccine against pertussis. Vaccine. 2008;26:4639-46.
76. Bottero D, Zurita ME, Gaillard ME, Bartel E, Vercellini C, Hozbor D. Membrane vesicles derived from bordetella bronchiseptica: active constituent of a new vaccine against infections caused by this pathogen. Appl Environ Microbiol. 2018;84:e01877-17.
77. Wang S, Gao J, Li M, Wang L, Wang Z. A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs). Biomaterials. 2018;187:28-38.
78. van der Pol L, Stork M, van der Ley P. Outer membrane vesicles as platform vaccine technology. Biotechnol J. 2015;10:1689-706.
79. van de Waterbeemd B, Zomer G, Kaaijk P, et al. Improved production process for native outer membrane vesicle vaccine against Neisseria meningitidis. PLoS One. 2013;8:e65157.
80. Thomas KJ 3rd, Rice CV. Revised model of calcium and magnesium binding to the bacterial cell wall. Biometals. 2014;27:1361-70.
81. Clifton LA, Skoda MW, Le Brun AP, et al. Effect of divalent cation removal on the structure of gram-negative bacterial outer membrane models. Langmuir. 2015;31:404-12.
82. Maredia R, Devineni N, Lentz P, et al. Vesiculation from Pseudomonas aeruginosa under SOS. ScientificWorldJournal. 2012;2012:402919.
83. Bauwens A, Kunsmann L, Karch H, Mellmann A, Bielaszewska M. Antibiotic-mediated modulations of outer membrane vesicles in enterohemorrhagic Escherichia coli O104:H4 and O157:H7. Antimicrob Agents Chemother. 2017;61:e00937-17.
84. Yun SH, Park EC, Lee SY, et al. Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202. Clin Proteomics. 2018;15:28.
85. Manning AJ, Kuehn MJ. Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol. 2011;11:258.
86. Balhuizen MD, Versluis CM, van Harten RM, et al. PMAP-36 reduces the innate immune response induced by Bordetella bronchiseptica-derived outer membrane vesicles. Curr Res Microb Sci. 2021;2:100010.
87. Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc Natl Acad Sci U S A. 2010;107:19002-7.
88. Sun B, Lv Z, Li R, et al. Synergistic dual-targeting bacterial extracellular vesicles delivering paclitaxel for precision glioblastoma therapy. Nano Lett. 2025;25:15468-77.
89. Kesty NC, Kuehn MJ. Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem. 2004;279:2069-76.
90. Kim SH, Kim KS, Lee SR, et al. Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. Biochim Biophys Acta. 2009;1788:2150-9.
91. Ojima Y, Yamaguchi K, Taya M. Quantitative evaluation of recombinant protein packaged into outer membrane vesicles of Escherichia coli cells. Biotechnol Prog. 2018;34:51-7.
92. Thakur M, Dean SN. Engineering outer membrane vesicles to carry enzymes: encapsulation, isolation, characterization, and modification. Methods Mol Biol. 2024;2843:177-94.
93. Galenkamp NS, Van Meervelt V, Mutter NL, van der Heide NJ, Wloka C, Maglia G. Preparation of cytolysin A (ClyA) nanopores. Methods Mol Biol. 2021;2186:11-8.
94. Fahie M, Romano FB, Chisholm C, Heuck AP, Zbinden M, Chen M. A non-classical assembly pathway of Escherichia coli pore-forming toxin cytolysin A. J Biol Chem. 2013;288:31042-51.
95. Murase K. Cytolysin A (ClyA): a bacterial virulence factor with potential applications in nanopore technology, vaccine development, and tumor therapy. Toxins. 2022;14:78.
96. Li Y, Zhao R, Cheng K, et al. Bacterial outer membrane vesicles presenting programmed death 1 for improved cancer immunotherapy via immune activation and checkpoint inhibition. ACS Nano. 2020;14:16698-711.
97. Tang S, Tang D, Zhou H, et al. Bacterial outer membrane vesicle nanorobot. Proc Natl Acad Sci U S A. 2024;121:e2403460121.
98. Thomas SC, Madaan T, Kamble NS, Siddiqui NA, Pauletti GM, Kotagiri N. Engineered bacteria enhance immunotherapy and targeted therapy through stromal remodeling of tumors. Adv Healthc Mater. 2022;11:e2101487.
99. Daleke-Schermerhorn MH, Felix T, Soprova Z, et al. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach. Appl Environ Microbiol. 2014;80:5854-65.
100. Chen J, Wei C, Pan C, et al. Genetically engineered Bacillus subtilis-derived extracellular vesicles Alleviates Ulcerative colitis by restoring intestinal barrier and regulating gut microbiota. Chem Eng J. 2025;512:162727.
101. Valguarnera E, Feldman MF. Glycoengineered outer membrane vesicles as a platform for vaccine development. Methods Enzymol. 2017;597:285-310.
102. Price NL, Goyette-Desjardins G, Nothaft H, et al. Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines. Sci Rep. 2016;6:24931.
103. Chen L, Valentine JL, Huang CJ, et al. Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies. Proc Natl Acad Sci U S A. 2016;113:E3609-18.
104. Long Q, Zheng P, Zheng X, et al. Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy. Adv Drug Deliv Rev. 2022;186:114321.
105. Cheng L, Peng D, Liu Z, et al. Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA. Biomaterials. 2026;327:123725.
106. Siadat SD, Vaziri F, Eftekhary M, et al. Preparation and evaluation of a new lipopolysaccharide-based conjugate as a vaccine candidate for brucellosis. Osong Public Health Res Perspect. 2015;6:9-13.
107. Micoli F, Alfini R, Di Benedetto R, et al. GMMA is a versatile platform to design effective multivalent combination vaccines. Vaccines. 2020;8:540.
108. Di Benedetto R, Alfini R, Carducci M, et al. Novel simple conjugation chemistries for decoration of GMMA with heterologous antigens. Int J Mol Sci. 2021;22:10180.
109. van den Berg van Saparoea HB, Houben D, Kuijl C, Luirink J, Jong WSP. Combining protein ligation systems to expand the functionality of semi-synthetic outer membrane vesicle nanoparticles. Front Microbiol. 2020;11:890.
110. Peng LH, Wang MZ, Chu Y, et al. Engineering bacterial outer membrane vesicles as transdermal nanoplatforms for photo-TRAIL-programmed therapy against melanoma. Sci Adv. 2020;6:eaba2735.
111. Zheng L, Hu B, Zhao D, et al. Recent progresses of exosome-liposome fusions in drug delivery. Chin Chem Lett. 2024;35:108647.
112. Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394.
113. Zhai Y, Ma Y, Pang B, et al. A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy. J Nanobiotechnology. 2021;19:434.
114. Pan X, Xian P, Li Y, et al. Chemotaxis-driven hybrid liposomes recover intestinal homeostasis for targeted colitis therapy. J Control Release. 2025;380:829-45.
115. Zhao X, Zhao R, Nie G. Nanocarriers based on bacterial membrane materials for cancer vaccine delivery. Nat Protoc. 2022;17:2240-74.
116. Wang D, Liu C, You S, et al. Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy. ACS Appl Mater Interfaces. 2020;12:41138-47.
117. Guo R, Du F, Xiang X, et al. Ultrasound-enhanced Pt-coordinated polymer immunopotentiators and heterogenic fusion membrane-based multifunctional tumor vaccine nanoplatforms for melanoma treatment. Signal Transduct Target Ther. 2025;10:278.
118. Wang F, Fan J, Pan W, et al. Probiotic-inspired hybrid nanovesicles for enhancing immune checkpoint therapy efficiency via tumor immune microenvironment modulation. Bioact Mater. 2026;56:197-216.
119. Liu G, Huang W, Chen L, et al. Commensal bacterial hybrid nanovesicles improve immune checkpoint therapy in pancreatic cancer through immune and metabolic reprogramming. Nano Today. 2023;52:101993.
120. Ayed Z, Cuvillier L, Dobhal G, Goreham R. Electroporation of outer membrane vesicles derived from Pseudomonas aeruginosa with gold nanoparticles. SN Appl Sci. 2019;1:1600.
121. Guo Q, Li X, Zhou W, et al. Sequentially triggered bacterial outer membrane vesicles for macrophage metabolism modulation and tumor metastasis suppression. ACS Nano. 2021;15:13826-38.
122. Li Y, Zhang K, Wu Y, et al. Antigen capture and immune modulation by bacterial outer membrane vesicles as in situ vaccine for cancer immunotherapy post-photothermal therapy. Small. 2022;18:e2107461.
123. Liang D, Liu C, Li Y, et al. Engineering fucoxanthin-loaded probiotics’ membrane vesicles for the dietary intervention of colitis. Biomaterials. 2023;297:122107.
124. Ban W, Sun M, Huang H, et al. Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy. Nat Commun. 2023;14:2933.
125. Huang W, Zhang Q, Li W, et al. Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism. J Control Release. 2020;317:1-22.
126. Didiot MC, Hall LM, Coles AH, et al. Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther. 2016;24:1836-47.
127. Yuan J, Yang J, Hu Z, et al. Safe staphylococcal platform for the development of multivalent nanoscale vesicles against viral infections. Nano Lett. 2018;18:725-33.
128. Bartolini E, Ianni E, Frigimelica E, et al. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles. 2013;2:20181.
129. Fantappiè L, de Santis M, Chiarot E, et al. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. J Extracell Vesicles. 2014;3:24015.
130. Han HS, Hwang S, Choi SY, et al. Roseburia intestinalis-derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses. J Extracell Vesicles. 2024;13:e12487.
131. Chen Q, Fang Z, Yang Z, et al. Lactobacillus plantarum-derived extracellular vesicles modulate macrophage polarization and gut homeostasis for alleviating ulcerative colitis. J Agric Food Chem. 2024;72:14713-26.
132. Tao S, Song M, Fan J, Zhu F, Lv T, Wei H. Lactobacillus johnsonii-derived extracellular vesicles carrying GAPDH protect against ulcerative colitis through modulating macrophage polarization. J Adv Res. 2026;81:409-24.
133. Pirolli NH, Levy D, Schledwitz A, et al. Genetically-programmed hypervesiculation of Lactiplantibacillus plantarum increases production of bacterial extracellular vesicles with therapeutic efficacy in a preclinical inflammatory bowel disease model. Adv Sci. 2026;13:e12679.
134. Pourtalebi Jahromi L, Kronast B, Munkert J, et al. Bioengineered bacterial vesicles and biomimetic hybrids eliminate biofilms and balance the gut microbiome. Small. 2026;22:e2502551.
135. Liu W, Yang J, Wei Z, et al. miRNA-loaded biomimetic nanoparticles orchestrate gut microbe to ameliorate inflammatory bowel disease. Sci Adv. 2025;11:eadw5984.
136. Wang M, Nian L, Zhang S, et al. Probiotics behavior‐inspired biomimetic platform for ulcerative colitis prevention and therapy. Adv Funct Mater. 2025;35:2505817.
137. Liu Q, Li B, Ma J, et al. Development of a recombinant outer membrane vesicles (OMVs)-based vaccine against Helicobacter pylori infection in mice. J Extracell Vesicles. 2025;14:e70085.
138. Liu Q, Li B, Lu J, et al. Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against Helicobacter pylori infection in mice. Infect Immun. 2023;91:e0031323.
140. Pearlman BL. How would you manage this patient with nonalcoholic fatty liver disease? Ann Intern Med. 2019;171:861-2.
141. Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21:6275.
142. Liu R, Zhang F, He X, Huang K. Plant derived exosome-like nanoparticles and their therapeutic applications in glucolipid metabolism diseases. J Agric Food Chem. 2025;73:6385-99.
143. Wang L, Liang A, Huang J. Exendin-4-enriched exosomes from hUCMSCs alleviate diabetic nephropathy via gut microbiota and immune modulation. Front Microbiol. 2024;15:1399632.
144. Kim JS, Song BJ, Cho YE. Pomegranate-derived exosome-like nanovesicles containing ellagic acid alleviate gut leakage and liver injury in MASLD. Food Sci Nutr. 2025;13:e70088.
145. Bajaj G, Choudhary D, Singh V, et al. MicroRNAs dependent G-ELNs based intervention improves glucose and fatty acid metabolism while protecting pancreatic β-cells in type 2 diabetic mice. Small. 2025;21:e2409501.
146. Han M, Wang J, Zhang Z, et al. Momordica Charantia L.-derived extracellular vesicles achieve pancreatic-targeted delivery and repair insulin-secretory function through dual mechanisms via lymphatic transport. Chem Eng J. 2025;520:165747.
147. Wang K, Li X, Xu X, et al. AI-driven target screening and microfluidic sonication-assembled oral delivery of fucoxanthin-loaded probiotic vesicles for targeted alleviation of diet-induced obesity. Chem Eng J. 2025;518:164598.
148. Lu T, Liu Y, Huang X, et al. Early-responsive immunoregulation therapy improved microenvironment for bone regeneration via engineered extracellular vesicles. Adv Healthc Mater. 2024;13:e2303681.
149. Liu H, Li R, Yang H, et al. Extracellular vesicles in gut-bone axis: novel insights and therapeutic opportunities for osteoporosis. Small Sci. 2025;5:2400474.
150. Han R, Zhou D, Ji N, et al. Folic acid-modified ginger-derived extracellular vesicles for targeted treatment of rheumatoid arthritis by remodeling immune microenvironment via the PI3K-AKT pathway. J Nanobiotechnology. 2025;23:41.
151. Liu Y, Tao S, Zhang Z, et al. Perilla frutescens leaf-derived extracellular vesicle-like particles carry Pab-miR-396a-5p to alleviate psoriasis by modulating IL-17 signaling. Research. 2025;8:0675.
152. Dell’Atti F, Abreu H, Malfa P, Raineri D, Cappellano G, Chiocchetti A. Probiotic-derived extracellular vesicles: the next breakthrough in postbiotics for rheumatoid arthritis. Front Immunol. 2025;16:1620185.
153. Liu H, Song P, Zhang H, et al. Synthetic biology-based bacterial extracellular vesicles displaying BMP-2 and CXCR4 to ameliorate osteoporosis. J Extracell Vesicles. 2024;13:e12429.
154. Zhou G, Zhou Q, Li R, et al. Synthetically engineered bacterial extracellular vesicles and IL-4-encapsulated hydrogels sequentially promote osteoporotic fracture repair. ACS Nano. 2025;19:16064-83.
155. Su D, Li M, Xie Y, et al. Gut commensal bacteria Parabacteroides goldsteinii-derived outer membrane vesicles suppress skin inflammation in psoriasis. J Control Release. 2025;377:127-45.
156. Luo Z, Cheng X, Feng B, et al. Engineering versatile bacteria-derived outer membrane vesicles: an adaptable platform for advancing cancer immunotherapy. Adv Sci. 2024;11:e2400049.
157. Zhuang WR, Xue WC, Liang C, et al. Bacterial foreignization nanosystem elicits multi-phenotypic T cells for antitumor immunity. Adv Sci. 2025;12:e04155.
158. Sun D, Li Y, Yin X, et al. Utilizing engineered bacteria as “cell factories” in vivo for intracellular RNA-loaded outer membrane vesicles’ self-assembly in tumor treatment. ACS Nano. 2024;18:35296-309.
159. Ahn W, Lee Y, Nam GH, You JB, Lee EJ. Bioengineered extracellular vesicles in emerging cancer vaccine platforms. Small Sci. 2025;5:2500270.
160. You H, Zhang S, Zhang Y, et al. Engineered bacterial outer membrane vesicles-based doxorubicin and CD47-siRNA Co-delivery nanoplatform overcomes immune resistance to potentiate the immunotherapy of glioblastoma. Adv Mater. 2025;37:e2418053.
161. Joe E, Ringman JM. Cognitive symptoms of Alzheimer’s disease: clinical management and prevention. BMJ. 2019;367:l6217.
162. Liu J, Wang T, Dong J, Lu Y. The blood-brain barriers: novel nanocarriers for central nervous system diseases. J Nanobiotechnology. 2025;23:146.
163. Rajendran L, Honsho M, Zahn TR, et al. Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006;103:11172-7.
164. Xin H, Li Y, Cui Y, Yang JJ, Zhang ZG, Chopp M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab. 2013;33:1711-5.
165. Xian P, Hei Y, Wang R, et al. Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019;9:5956-75.
166. Zhang Y, Lu L, Li Y, Liu H, Zhou W, Zhang L. Response surface methodology optimization of exosome-like nanovesicles extraction from lycium ruthenicum murray and their inhibitory effects on Aβ-induced apoptosis and oxidative stress in HT22 cells. Foods. 2024;13:3328.
167. Yu Y, Xu Z, Xu L, Lu D, Tang Y, Mai H. Plant extracellular vesicles as emerging neuroprotective agents for central nervous system disorders. J Adv Res. 2026;79:879-89.
168. Sun B, Sawant H, Borthakur A, Bihl JC. Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders. Front Neurosci. 2023;17:1241418.
169. Arenas YM, Pérez-Martinez G, Montoliu C, Llansola M, Felipo V. Extracellular vesicles from L. paracasei improve neuroinflammation, GABA neurotransmission and motor incoordination in hyperammonemic rats. Brain Behav Immun. 2025;123:556-70.
170. Kwon H, Lee EH, Park SY, et al. Lactobacillus-derived extracellular vesicles counteract Aβ42-induced abnormal transcriptional changes through the upregulation of MeCP2 and Sirt1 and improve Aβ pathology in Tg-APP/PS1 mice. Exp Mol Med. 2023;55:2067-82.
171. Qin Y, Chen X, Bao L, et al. Lipid metabolism of apoptotic vesicles accelerates cutaneous wound healing by modulating macrophage function. J Nanobiotechnology. 2025;23:106.
172. Yuan S, Jin M, Zhang Y, et al. Extracellular vesicles in skin: biological function and therapeutic potential. Int J Nanomedicine. 2025;20:11211-33.
173. Wu W, Zhang B, Wang W, et al. Plant-derived exosome-like nanovesicles in chronic wound healing. Int J Nanomedicine. 2024;19:11293-303.
174. Wang J, Li X, Zhao X, et al. Lactobacillus rhamnosus GG-derived extracellular vesicles promote wound healing via miR-21-5p-mediated re-epithelization and angiogenesis. J Nanobiotechnology. 2024;22:644.
175. Li Y, Zheng Z, Kong X, et al. Bacteria extracellular vesicles derived from Lactobacillus reuteri delivering intrinsic miR-21a-5p to accelerate diabetic wound healing. Nano Research. 2025;18:94908083.
176. Chen Y, Huang X, Liu A, et al. Lactobacillus reuteri vesicles regulate mitochondrial function of macrophages to promote mucosal and cutaneous wound healing. Adv Sci. 2024;11:e2309725.
177. Chen J, Li B, Wei C, et al. Bacillus subtilis-derived extracellular vesicles displaying superoxide dismutase exhibit superior antioxidant ability in ameliorating skin damage. Int J Biol Macromol. 2026;339:150031.
178. Oh SY, Kim DY, Lee KY, et al. Streptococcus mutans-derived extracellular vesicles promote skin wound healing via tRNA cargo. J Nanobiotechnology. 2025;23:322.
179. Yuan P, Deng M, Li X, et al. Lactobacillus extracellular vesicle-driven oxygen-releasing photothermal hydrogel reprograms macrophages and promotes angiogenesis to accelerate diabetic wound healing. Bioact Mater. 2025;54:144-58.
180. Kang S, Jeon S, Baek H, et al. Lactobacillus-derived artificial extracellular vesicles for skin rejuvenation and prevention of photo-aging. Biomater Sci. 2025;13:2026-35.
181. Guo J, Huang Z, Wang Q, et al. Opportunities and challenges of bacterial extracellular vesicles in regenerative medicine. J Nanobiotechnology. 2025;23:4.
182. Huang C, Cao W, Zhou S, Deng Y. Biogenesis mechanisms, regulatory strategies, and applications of bacterial extracellular vesicles. Crit Rev Biotechnol. 2025;45:1700-16.
183. Rima M, Dakramanji M, El Hayek E, El Khoury T, Fajloun Z, Rima M. Unveiling the wonders of bacteria-derived extracellular vesicles: From fundamental functions to beneficial applications. Heliyon. 2025;11:e42509.
184. Effah CY, Ding X, Drokow EK, Li X, Tong R, Sun T. Bacteria-derived extracellular vesicles: endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis. Front Immunol. 2024;15:1296061.
185. Marquez-Paradas E, Torrecillas-Lopez M, Barrera-Chamorro L, Del Rio-Vazquez JL, Gonzalez-de la Rosa T, Montserrat-de la Paz S. Microbiota-derived extracellular vesicles: current knowledge, gaps, and challenges in precision nutrition. Front Immunol. 2025;16:1514726.
186. Chen MY, Cheng TW, Pan YC, et al. Endotoxin-free outer membrane vesicles for safe and modular anticancer immunotherapy. ACS Synth Biol. 2025;14:148-60.
187. Bai X, Li C, Qiu J, et al. A “plug-and-display” nanoparticle based on attenuated outer membrane vesicles enhances the immunogenicity of protein antigens. J Control Release. 2025;378:687-700.
188. Wegmann U, Carvalho AL, Stocks M, Carding SR. Use of genetically modified bacteria for drug delivery in humans: revisiting the safety aspect. Sci Rep. 2017;7:2294.
